Lymphatic drainage dysfunction is related to clinically significant portal hypertension Ruixue MaYasuko Iwakiri Editorial 24 September 2023 Pages: 1327 - 1330
Ending stigmatizing language in alcohol and liver disease: a liver societies’ statement European Association for the Study of the LiverAmerican Association for the Study of Liver DiseasesAsian Pacific Association for the Study of the Liver Editorial 27 September 2023 Pages: 1331 - 1332
How non-alcoholic fatty liver disease and cirrhosis affect the heart Søren MøllerSigne WieseJens D. Hove Review Article 28 September 2023 Pages: 1333 - 1349
Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosis Yuanyuan KongYameng SunJidong Jia Original Article 19 August 2023 Pages: 1350 - 1358
Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection Anika WrankeBenjamin HeidrichHeiner Wedemeyer Original Article Open access 03 October 2023 Pages: 1359 - 1367
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding Zhiying HeBingqiong WangHong You Original Article 29 September 2023 Pages: 1368 - 1377
Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis Yoshiaki SugiyamaKenta YamamotoHiroki Kawashima Original Article 04 September 2023 Pages: 1378 - 1392
The causes of death in patients with nonalcoholic steatohepatitis following liver transplantation stratified using pre-liver transplant BMI David Uihwan LeeAneesh BahadurZurabi Lominadze Original Article 09 May 2023 Pages: 1393 - 1415
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort Jing ZengQian JinJian-Gao Fan Original Article 20 September 2023 Pages: 1416 - 1428
Molecular evolution in different subtypes of multifocal hepatocellular carcinoma Xia TangLei XiangKeyue Ding Original Article 05 June 2023 Pages: 1429 - 1443
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression Qingcan SunMengying ShenLi Liu Original Article 19 May 2023 Pages: 1444 - 1460
Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA Chenhao ZhouJialei WengNing Ren Original Article 23 May 2023 Pages: 1461 - 1476
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients Kong-Ying LinZhi-Wen LinYong-Yi Zeng Original Article 29 June 2023 Pages: 1477 - 1489
Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression Yi XuYue YaoJudy Wai Ping Yam Original Article Open access 24 June 2023 Pages: 1490 - 1499
MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way Shiji FangLiyun ZhengJiansong Ji Original Article 17 July 2023 Pages: 1500 - 1518
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy Jingzhong OuyangYi YangJinxue Zhou Original Article 14 September 2023 Pages: 1519 - 1531
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome Benedikt SimbrunnerIda Falk VillesenMattias Mandorfer Original Article Open access 21 August 2023 Pages: 1532 - 1544
3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study Xiaoqiong ChenTao WangSirui Fu Original Article Open access 02 August 2023 Pages: 1545 - 1556
Lymphatic drainage dysfunction via narrowing of the lumen of cisterna chyli and thoracic duct after luminal dilation Ryo YanoMasashi HirookaYoichi Hiasa Original Article 27 July 2023 Pages: 1557 - 1569
Live donor liver transplantation for pediatric acute liver failure: challenges and outcomes Viniyendra PamechaNilesh Sadashiv PatilBikrant Bihari Lal Original Article 16 August 2023 Pages: 1570 - 1586
Pure laparoscopic versus open left lateral hepatectomy in pediatric living donor liver transplantation: a review and meta-analysis Meng ShaZhi-peng ZongQiang Xia Original Article 05 January 2023 Pages: 1587 - 1595
Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma Kevin Tak-Pan NgJiang LiuKwan Man Original Article 05 August 2023 Pages: 1596 - 1609
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients Silke LeonhardtChristian JürgensenFrank Tacke Original Article Open access 29 April 2023 Pages: 1610 - 1625
Clinic-radiomics model using liver magnetic resonance imaging helps predict chronicity of drug-induced liver injury Haoshuang FuZhehan ShenQing Xie Original Article 15 May 2023 Pages: 1626 - 1636
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic Humberto C. GonzalezFaisal M. NimriStuart C. Gordon Original Article 28 July 2023 Pages: 1637 - 1644
Gut microbiota regulates circadian oscillation in hepatic ischemia–reperfusion injury-induced cognitive impairment by interfering with hippocampal lipid metabolism in mice Zhigang HeYanbo LiuJun Xiong Original Article Open access 01 April 2023 Pages: 1645 - 1658
Therapeutic role of FNDC5/irisin in attenuating liver fibrosis via inhibiting release of hepatic stellate cell-derived exosomes Xin LiaoYilin LuoQin Yang Original Article 12 April 2023 Pages: 1659 - 1671
